מושגי ליבה
MRI-guided biopsies for prostate cancer are cost-effective.
סטטיסטיקה
Cost-effectiveness defined as less than $100,000 for each life-year gain using MRI.
MRI-based approach cost $6000 more than ultrasound for life-year gain at PSA level >10.0 ng/mL.
Difference between MRI and ultrasound at PSA level <2.5 ng/mL was $187,000.
ציטוטים
"A growing consensus that the use of MRI and potential MRI-guided biopsy is cost-effective."